Oncopeptides AB (ONCO) Income Statement

Last quarter (Q4 2024), Oncopeptides AB's total revenue was kr9.91M, an increase of 85.76% from the same quarter last year. In Q4, Oncopeptides AB's net income was kr-83.43M. See Oncopeptides AB’s key income statements, including revenue, expenses, profit, and income.